Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: patron_anejo_por_favor who wrote (117770)	8/21/2001 12:40:56 PM
From: yard_man	Respond to of 436258

looks good. good luck. I just checked for grins to see if I could get shares -- I can't.

To: patron_anejo_por_favor who wrote (117770)	8/21/2001 12:48:16 PM
From: yard_man	Read Replies (1) \| Respond to of 436258

got an opinion on KKD -- not fundamentally -- but technically?

To: patron_anejo_por_favor who wrote (117770)	8/21/2001 12:53:09 PM
From: oldirtybastard	Read Replies (2) \| Respond to of 436258

I'm selling more EBAY today, may even get some poots if they can crank it a little higher. Waiting for more MSCC at 60 but it would be too much of a gift if they get it there imo My MER calls are doing well, I'll probably hold them through the fed. I still have a nagging idea in the back of my mind there could be a decent rally if greenspan says some words that entrance the clowns and I wouldn't mind making some money off of it. Besides, what kind of lunacy do the dudes at Goldman have in mind pushing out Abby the stockwhore with her still way too high predictions? They know they will look REALLY stupid, yet again, if wrong. Maybe they are relying on clowns memories getting even shorter, wtf knows? What goal do they have in mind that is more important than their image?

To: patron_anejo_por_favor who wrote (117770)	8/21/2001 1:52:09 PM
From: robnhood	Read Replies (1) \| Respond to of 436258

<<<-- Med-Design Responds to Spurious Chat Room Rumors and Attacks -- /FROM PR NEWSWIRE PHILADELPHIA 800-523-4424/ TO BUSINESS EDITOR: Med-Design Responds to Spurious Chat Room Rumors and Attacks VENTURA, Calif., Aug. 21 /PRNewswire/ -- The Med-Design Corporation (Nasdaq: MEDC), a leader in the design and development of safety-engineered needle products for medical use, today was forced to respond to libelous and blatantly false statements posted on an Internet chat room. While it is not policy of the Company to respond to anonymous chat room rumors, these inaccurate and libelous statements have resulted in various investor inquires, which have distracted management. In addition, these blatantly false statements may have negatively impacted the performance of Med-Design stock. As a result, and to ensure compliance with SEC Fair Disclosure regulations, management is compelled to issue a public statement addressing these wholly inaccurate claims. James Donegan, Chairman and CEO of The Med-Design Corporation, and the Company's largest individual shareholder, is not, never has, nor will he in the future collar or otherwise sell any derivative/hedged position on his holdings in The Med-Design Corporation. None of Mr. Donegan's stock holdings are or ever were hedged or collared by Bank of America or any other financial institution. Furthermore, Mr. Donegan has not sold any Med-Design stock since November 2000 when he exercised a warrant. The Company has authorized its outside attorneys to attempt to identify the author of said libelous statements and institute appropriate legal action. Finally, given the current legislative environment and the overwhelming support from health care practitioners, Med-Design believes that safety is here to stay. The Company also believes that the marketplace for quality, user-friendly safety-engineered needle devices is large enough to allow healthy competition. Med-Design stands by its position that Retractable Technologies' recent 8-K attack is inaccurate; however, the company does not intend to engage in a public debate with any competitor who attacks Med-Design in an attempt to distract the public from focusing on the competitor's inadequacies.>>